Waldenstrom macroglobulinemia is a chronic, slow-growing lymphoproliferative disorder. It usually affects older adults and is primarily found in the bone marrow . Waldenström macroglobulinemia (WM) is a distinct clinicopathologic entity demonstrating lymphoplasmacytic lymphoma (LPL) in the bone. Waldenström macroglobulinemia is often an indolent disorder, and many patients are candidates for observation with careful monitoring.

Author: Tokazahn Kigashicage
Country: Ethiopia
Language: English (Spanish)
Genre: Travel
Published (Last): 1 May 2014
Pages: 38
PDF File Size: 3.27 Mb
ePub File Size: 1.42 Mb
ISBN: 635-6-58681-159-5
Downloads: 35517
Price: Free* [*Free Regsitration Required]
Uploader: Arasar

Waldenström’s macroglobulinemia

Similar to other plasma cell dyscrasias that, for example, lead to multiple myelomaWM is commonly preceded by two clinically asymptomatic but progressively more pre-malignant phases, IgM monoclonal gammopathy of undetermined significance i.

In patients at low risk, the average survival time is 12 years, and treatment should involve low toxicity, preserving quality of life.

June 04, ; Accepted: Orellana J, Friedman AH. Coagulation abnormalities may be present.

There is a higher incidence in individuals aged between 63 and 68 years. The infiltration of malignant enfermedac in the central nervous system is responsible for a rare neurological disorder called Bing-Neel syndrome. Curr Treat Options Oncol.

Treatment includes the monoclonal antibody rituximabsometimes in combination with chemotherapeutic drugs such as chlorambucilcyclophosphamideor vincristine or with thalidomide.

There is no walddenstrom accepted treatment for WM. J Am Acad Dermatol. Screening of AL amyloidosis – electrophoresis and immunofixation of urinary proteins hour urine.

Arch Pathol Lab Med. Useful in patients with Raynaud’s syndrome, acrocyanosis or limb ulceration.

This page was last edited on 20 Decemberat Initial immunoglobulin M ‘flare’ after rituximab therapy in patients diagnosed with Waldenstrom macroglobulinemia. Differential diagnosis of other malignancies of B-lymphocytes secreting monoclonal IgM.


Renal infiltration has also been reported, 49 as well as cutaneous infiltration maculopapular lesions, plaques or nodules 750 and infiltration of periorbital structures, such as the tear gland and retro-orbital lymphoid tissue ocular tremors. Immunophenotypic variations may occur. Rituximab is an IgG1 anti-CD20 monoclonal antibody.

Other immunophenotypic characteristics of neoplastic B-lymphocytes: Internal Medicine 5th ed. The WM is a rare disease with a typically indolent clinical course, affecting mainly individuals aged between 63 and 68 years.

The most frequent neurological disorder is a demyelinating distal symmetrical sensorimotor peripheral neuropathy, which manifests itself slowly and progressively, causing paresthesia and asthenia. Evaluation of thrombocytopenia and anemia, which is usually normocytic and normochromic Search autoimmune hemolytic anemia.

It is believed that WM originates in memory B-lymphocytes. First-line therapy includes alkylating agents, purine analogs and monoclonal anti-CD20 antibodies. The treatment of asymptomatic patients does not improve their quality of life and survival; 3 biannual clinical observation is the recommended option in these cases if hematologic function is preserved.

Am J Clin Pathol. Prothrombin timeactivated partial thromboplastin timethrombin timeand fibrinogen tests should be performed. Pruzanski W, Shumak KH. Most lymphomas have a similar immunophenotype to MALT lymphoma, others have a similar immunophenotype to splenic marginal zone lymphomas. Other lymphoproliferative diseases, including marginal zone B-cell lymphoma, chronic lymphocytic leukemia and mantle cell lymphoma should be excluded. A pathologist identifies the particular lymphocytes that indicate WM.

Assess the bone marrow infiltration by lymphocytes, the infiltration pattern and cell morphology. Otherwise, another first-line agent or combination therapy should be used.

  HP ENVY 700-040D PDF

Peripheral neuropathy in essential mixed cryoglobulinemia. Apropos of a new case. Associated symptoms are nystagmus, diplopia, vertigo, memory loss, mental confusion, motor dysfunction and waldenstrrom coma. Additional tests such as computed tomography CT or CAT scan may be used to evaluate the chest, abdomen, and pelvis, particularly swelling of the lymph nodes, liver, and spleen.

The article refers to them as “adverse covariates”.

WM patients are at higher risk of developing second cancers than the general population, but it is not yet clear whether treatments enfernedad contributory. Lia; Advani, Ranjana H.

Retrieved from ” https: Prognostic factors in symptomatic Waldenstrom’s macroglobulinemia. Cancer Management and Research. Guidelines on the management of Waldenstrom macroglobulinaemia.

In primary or light chain amyloidosis AL amyloidosisamyloid fibrils may be deposited in the heart, kidneys, liver, lungs and peripheral nerves. There are different treatment flowcharts: Rua do Campo Alegre,Postal Code: Despite the high incidence of HCV infection in these patients, a statistically significant association between HCV infection and WM has not been found.

Waldenström’s macroglobulinemia – Wikipedia

Some of these markers are particularly useful for studying the bone marrow infiltrate in the bone biopsy through immunohistochemical and other studies for the immunophenotypic characterization of B-lymphocytes by flow cytometry. CDCD70 interactions in the pathogenesis of Waldenstrom macroglobulinemia. Nodular, interstitial, diffuse or mix of all three.